Martha Stewart joins the cannabis industry as a brand ambassador for Canopy Growth’s (NYSE:CGC,TSX:WEED) lineup of products in the US market.

Canopy, in partnership with Sequential Brands Group (NASDAQ:SQBG), confirmed the new role for the celebrity businesswoman and television personality.

Stewart will aid in the development of Canopy’s new line of hemp derived cannabidiol (CBD) products in the US.

“I’m especially looking forward to our first collaboration together, which will offer sensible products for people’s beloved pets,” Stewart said.

Canopy announced it holds “several clinical trials underway” for the effectiveness of CBD and other cannabinoids to improve the health of humans and animals.

The Canadian firm indicated it will rely on Stewart’s knowledge of consumer products.

Shares of Canopy jumped in New York and Toronto, with the company raising in value 3.63 and 3.67 percent at the closing bell on Thursday.

The company finished with a price per share of US$47.41 and C$62.38 respectively.

In January, Canopy announced it would break through to the US market, thanks to the passing of a US$867-billion farm bill legalizing hemp and its derivatives including CBD.

The Canadian firm will invest between US$100 million and US$150 million for its new production plans in New York.

Stewart has raised her profile in the cannabis space thanks to a cooking television show, “Martha & Snoop’s Potluck Dinner Party” co-hosted with rapper Snoop Dogg, which also led to the sale of a cookbook.

“Martha is one of a kind and I am so excited to be able to work alongside this icon to sharpen our CBD product offerings across categories from human to animal,” Bruce Linton, Canopy chairman and co-CEO said in a press release.

Canopy did not offer specific terms of the partnership or payment or compensation specifics for the deal.

Canadian cannabis firm finds celebrity partnerships in the US

Through this partnership, Canopy is able to capitalize on a core difference between the US and Canadian cannabis markets.

Health Canada, the government agency tasked with regulated the marijuana industry in the country, has placed strong policies on the role celebrities can have with regards to the promotion of cannabis-based products and companies.

While Canada has legalized the drug for adult consumption first, its heavy restrictions on promotions and partnerships have left companies to scramble for brand awareness plans.

Now, Canopy has attached its name to Stewart and her business savviness thanks to its US strategy.

However, some celebrities have found ways into the Canadian cannabis investing space through business partnerships.

Newstrike Brands (TSXV:HIP,OTC Pink:NWKRF) signed Canadian rock band The Tragically Hip to a multi-year deal and Invictus MD (TSXV:GENE,OTCQX:IVITF) performed a similar manoeuvre by signing Gene Simmons to the role of “chief evangelist officer.”

In these cases, both marijuana firms changed their ticker symbols on the TSX Venture Exchange (TSXV) to “HIP” and “GENE” to reflect these partnerships.

Despite the partnerships, the cannabis companies are not allowed to sell products on the basis of these celebrity endorsements, while Canopy already touts Stewart’s brand awareness with consumer products.

As the Cannabis Act was enacted last October, several celebrity deals in place with cannabis companies were scrapped for the Canadian market as part of the heavy restrictions in place.

“If a name can, in and of itself, be a ‘depiction,’ then yes this will have an impact on branding. Any brand referencing a celebrity by name will be offside in that case,” Trina Fraser, a business lawyer at Brazeau Seller Law told Marijuana Business Daily.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Invictus MD is a client of the Investing News Network. This article is not paid-for content.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less